SCHEMBL274028

SCHEMBL274028

CC(O)CN(Cc1cccc(C(=O)Nc2ccc(N3CCCC3=O)cc2C(=O)N/N=C/c2ccc(Cl)c(C(F)(F)F)c2)c1)CC(C)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC34A2 O95436 12/20 0.47
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
GFER P55789 2/20 0.45
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
POLB P06746 2/20 0.40
SLC34A1 Q06495 1/20 0.40
SLC34A3 Q8N130 1/20 0.40
SLC20A1 Q8WUM9 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268851 1.00 SLC34A2 (0.47) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL268850 1.00 SLC34A2 (0.47) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL268692 0.90 SLC34A2 (0.47) SLC34A2ALDH1A1SLC34A1SLC34A3SLC20A1
SCHEMBL10261251 0.90 SLC34A2 (0.47) SLC34A2ALDH1A1SLC34A1SLC34A3SLC20A1
SCHEMBL268691 0.90 SLC34A2 (0.47) SLC34A2ALDH1A1SLC34A1SLC34A3SLC20A1
SCHEMBL267076 0.89 ALDH1A1 (0.52) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL267075 0.89 ALDH1A1 (0.52) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL265719 0.88 KDM4E (0.48) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL265718 0.88 KDM4E (0.48) SLC34A2ALDH1A1KDM4EMAPTGFER
SCHEMBL266111 0.88 KDM4E (0.51) ALDH1A1KDM4EMAPTGFERGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 US disclosed
US-8134015-B2 Compound inhibiting in vivo phosphorous transport and medicine containing the same KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-03-13 US disclosed
US-8134015-B2 Compound inhibiting in vivo phosphorous transport and medicine containing the same KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME SLC34A1, SLC34A2, SLC20A2 SLC34A2 2/4885ALDH1A1 2872/4885KDM4E 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.